SUMMARY In order to determine the mechanism underlying prolongation of the pre-ejection period in patients with left ventricular disease, 11 patients with congestive cardiomyopathy and 29 with coronary artery disea3e, 10 of whom were taking beta-adrenergic blocking drugs, were studied non-invasively. Recordings of carotid pulse, and apex, phon-, and echocardiogram were obtained. In the absence of treatment with beta-blocking drugs, prolongation of pre-ejection period correlated closely with incoordinate left ventricular wall movement during isovolumic contraction assessed from simultaneous apex and echocardiograms. There was no correlation between pre-ejection period index (PEPI) and end-diastolic dimension and PEPI correlated poorly with fractional shortening and peak Vcf. A PEPI of greater than 140 ms was associated with incoordinate contraction in all but one case, and of less than 140 ms with normal contraction in all. Therapeutic doses of beta-blocking drugs caused prolongation of PEPI to a greater extent than would have been predicted from wall movement during isovolumic contraction. Incoordinate left ventricular contraction and a negative inotropic effect both therefore prolong PEPI, but by different mechanisms, whose effects can be separated in individua patients using non-invasive methods based on echocardiography.
Prolongation of pre-ejection period is commonly used to detect the presence of left ventricular disease, though the mechanism of this prolongation of pre-ejection period is obscure. A reduction in 'contractility' is frequently invoked, but this term is not adequately defined, and means little more than the presence of clinical evidence of left ventricular disease. We have, therefore, measured pre-ejection period and other systolic time intervals in patients with ischaemic heart disease or cardiomyopathy, analysing any impairment of left ventricular function at rest in terms of abnormal cavity size, incoordinate contraction, and reduced peak systolic rate of wall movement, measured echocardiographically. These observations were compared with those made during chronic administration of beta-blocking drugs in therapeutic dosage.
Methods
Systolic time intervals were measured and echocardiographic examinations were performed in 40 patients, who were divided into the following groups:
Group 1: 11 patients with congestive cardiomyoReceived for publication 15 January 1979 pathy. This diagnosis was made by echocardiography in patients without a history of chest pain or electrocardiographic evidence of infarction, in whom cavity size was increased and the amplitude of wall movement reduced. Since we no longer perform cardiac catheterisation in such patients, this group may have included individuals with advanced ischaemic heart disease. This limitation was accepted, since the pathological process underlying the left ventricular disease was of no importance to the design of the study.
Group 2: 19 patients with coronary artery disease, confirmed by coronary arteriography. None of these patients had taken any beta-adrenergic blocking drug within 2 weeks of the study. (1) Total electromechanical systole (Q-S2): this was measured from the onset of left ventricular depolarisation to the start of the first high-frequency vibration of the aortic component of the second heart sound.
(2) Left ventricular ejection time (LVET): this was measured from the onset of the rapid upstroke of the carotid pulse to the trough of the incisura.
(3) Pre-ejection period (PEP): this was derived by subtracting left ventricular ejection time from Q-S2 interval. All intervals were measured to the nearest 5 ms from 10 successive beats, and average values obtained. Using regression equations derived by Weissler et al. (1969b) , the pre-ejection period index (PEPI) was calculated. In addition, values of the ratio PEP/LVET were also derived. Echocardiograms and apex cardiograms were digitised as previously described (Venco et al., 1977 
Results
The systolic time intervals and echocardiographic measurements in the 3 groups of patients are given in detail in Table 1 .
In groups 1 and 2, PEPI was found to correlate most strongly with left ventricular dimension change during the upstroke of the apex cardiogram (r=0-76, P < 0 001). There was no significant correlation with end-diastolic dimension (r=0-22, NS) and correlation was poor with fractional shortening (r =0-39, P < 0 5) and peak Vcf (r =0-42, P <0 05). The relation between PEPI and dimension change during the upstroke of the apex cardiogram is shown in Fig. 1 . Of 10 patients with PEPI less than 140ms, all had a left ventricular dimension change less than 15 per cent, the upper limit of normal (Venco et al., 1977) , while 19 of the remaining 20 had a left ventricular dimension change greater than 15 per cent. This relation is very significant statistically (Fisher's exact probability test, P<0 0001).
The PEP/LVET ratio in groups 1 and 2 also correlated best with left ventricular dimension change during the upstroke of the apex cardiogram (r=0-77, P<0.001), but also, to a lesser extent, with fractional shortening (r = -0-53, P < 0 002) and peak Vcf (r = -0 49, P < 0.01). There was no significant correlation with end-diastolic dimension.
Multiple correlation on PEP/LVET, peak Vcf, and left ventricular dimension change resulted in the following regression equation:
PEP/LVET = 0 35 -0-038 peak Vcf + 0-0084 (dimension change). The multiple correlation coefficient was 0 79. In addition, peak Vcf and fractional shortening were themselves significantly correlated (r=0 90), and so could not be treated as independent variables. In group 3 patients, who were taking therapeutic doses of beta-blocking drugs, values of PEPI were greater than would have been predicted from dimension change during isovolumic contraction in 9 out of 10 patients (Fig. 2) .
Discussion
There is much evidence to suggest that the preejection period is prolonged by the presence of left ventricular disease. This has been reviewed in detail by Harris (1974) , and shown to be true not only for primary myocardial disease (Spodick et al., 1972; Armstrong et al., 1973) , but also for the myocardial disease occurring in hypertension (Tarazi et al., 1969) , valvar heart disease, or coronary artery disease (Jezek, 1963; Pouget et al., 1971; Meng et al., 1976) . However, analysis of the underlying disturbance has been limited by difficulties in the definition of myocardial contractility. This has been defined in terms of the findings of experiments on isolated heart muscle, whose theoretical basis now appears dubious, and (Gibson, 1973) . At end-diastole, these are little affected by an incoordinate left ventricular contraction pattern (Ludbrook et al., 1973) . Measurement of peak Vcf has also been validated against angiocardiography, and in patients with a co-ordinate contraction pattern and competent mitral valve it has been shown to correlate closely with peak left ventricular dP/dt (Gibson and Brown, 1975a, 1976) . Finally, abnormal changes in left ventricular dimension during the time of inscription of the upstroke of the apex cardiogram between the onset and the 'E' point correlate closely with regional disturbances of wall movement during early systole, shown angiographically , independent of other abnormalities of left ventricular wall movement that may be present. Pre-ejection period index ( ms) Fig. 2 Effect of therapeutic doses of beta-adrenergic blocking drugs on relation between pre-ejection period and abnormal dimension changes during isovolumic contraction. The regression line is derived from data of Fig. 1 .
The present results show clearly that prolongation of pre-ejection period is associated with abnormal dimension changes during the upstroke of the apex cardiogram, but not with either an increased transverse cavity dimension or a reduced peak Vcf. It might be objected that some of these measurements of cavity size or peak Vcf were obtained in patients with incoordinate wall movement and are, therefore, not representative of the behaviour of the left ventricle as a whole. However, they are clearly abnormal, whether or not they are representative, and so should have been associated with values of PEPI outside the normal range, if they were indeed the basis of the prolongation of preejection period seen in patients with heart disease. Secondly, when the subgroup of patients was considered in whom apex cardiogram dimension relations were normal and thus in whom contraction patterns would be expected to be more uniform, the same lack of correlation was found. Thus normal values of PEPI were seen in association with cavity dimensions of up to 8-2 cm, fractional shortening as low as 0-15, or a peak Vcf of 0-65 s-1.
A second limitation of the study is that dimension changes during the upstroke of the apex cardiogram have been shown to be sensitive and specific in detecting, but not necessarily in quantifying, the degree of incoordinate contraction judged angiographically. It is probably more appropriate, therefore, to use this method simply to categorise early systolic wall movement in individual patients as either normal or abnormal. When groups 1 and 2 patients were divided in this way, there was virtually no overlap between the two (Table 2) . Nevertheless, the relation between the percentage dimension change during isovolumic contraction and prolongation of PEPI (Fig. 1) suggests that these measurements may, in fact, be regarded as semiquantitative. We therefore conclude that prolongation of pre-ejection period in untreated patients with coronary artery disease or cardiomyopathy is the Fisher exact probability test, P < 0 0001. 307 vJ group.bmj.com on June 3, 2017 -Published by http://heart.bmj.com/ Downloaded from result of asynchronous onset of contraction rather than slow contraction or abnormal cavity size.
The o_currence of abnormal wall movement early in systole has been recognised in patients with coronary artery disease for some years, and was described in detail by Karliner et al. (1971) and, more recently, by Gibson et al. (1978) , using techniques for displaying regional left ventricular wall movement so that such abnormalities of timing could be easily appreciated. Left ventricular contraction patterns in patients with congestive cardiomyopathy were described by Kreulen et al. (1973) , who noted that in approximately 50 per cent there was angiocardiographic evidence of incoordinate movement. In all these patients, the method of angiographic analysis is of importance. Although the most obvious abnormalities seen on direct inspection of the cine film are those of regional amplitude of wall movement, these areas do not necessarily show disturbed movement in early systole. Conversely, regions behaving abnormally in early systole frequently undergo a normal amplitude of movement later in ejection, though their timing may be delayed compared to the remainder of the ventricle . It has previously been shown that abnormal dimension changes during the upstroke of the apex cardiogram correlate specifically with those shown angiographically to occur in early systole, and are unrelated to regional reduction in amplitude . Prolongation of pre-ejection period in our patients, therefore, is also likely to have been related specifically to these early systolic regional abnormalities of wall movement. This correlation would not have been detected unless the methods used had been based on a technique of angiographic analysis capable of distinguishing these disturbances of timing from the more commonly recognised ones of amplitude.
If activation is normal, then pre-ejection period depends on end-diastolic aortic and left ventricular pressures and the rate of rise of the left ventricular pressure pulse. Since hypertensive patients were not studied, and since left atrial pressure is likely to have been high rather than low in the presence of left ventricular disease, prolonged pre-ejection period in our patients was the result of reduced rate of left ventricular pressure rise. Such a reduction in peak left ventricular dP/dt has been shown in dogs by Rushmer (1956) by inducing incoordinate contraction using ventricular pacing. These observations were confirmed in man by Gibson and Brown (1975b) , who showed that reduction in peak dP/dt correlated with the distortion of the left ventricular pressure dimension loop. The present results are compatible with these findings, and suggest that incoordinate left ventricular contaction during early systole causes the appearance of disturbed time relations between changes in dimension and the apex cardiogram, and also prolongs pre-ejection period by reducing the rate of rise of left ventricular pressure, thus explaining the statistical association between the two.
Pre-ejection period is also prolonged by propranolol in normal subjects and patients with heart disease (Harris et al., 1967; Hunt et al., 1970) . This finding was confirmed in the present study, where it was also apparent that it was not associated with the expected degree of dimension change early in systole, suggesting that the mechanism by which it was brought about was different from that associated with heart disease. Though there is some evidence that propranolol administration may aggravate abnormalities of wall movement in patients with ischaemic heart disease (Helfant et al., 1971) , other studies have shown either no change (Shubrooks et al., 1975) or an improvement (Coltart et al., 1975) . It, therefore, seems reasonable to suppose that prolongation of pre-ejection period by propranolol reflects a reduction in contraction velocity due simply to its activity as a beta-adrenoceptor blocking drug. The methods we have used are capable of distinguishing between slow contraction and incoordinate contraction, not only when they occur separately, but also when they occur together in the same patient. In contrast, both mechanisms cause pre-ejection period to be prolonged, and so cannot be distinguished using this latter method alone. It cannot be suggested, therefore, that left ventricular disease and drugs with a negative inotropic effect have the same action on the myocardium merely because they both prolong the pre-ejection period.
Abnormalities of left ventricular function have also been related to the ratio PEP/LVET. This was shown, in a large group of patients with heart disease of different types, to correlate with ejection fraction (Garrard et al., 1970) . However, when patients with coronary artery disease alone were considered, there was no such correlation. This lack of correlation has since been confirmed by other workers (Parker and Just, 1974) , though we were unable to confirm or deny this relation in the present study. Nevertheless, the demonstration of greatly increased cavity size, reduced amplitude of wall movement, and normal PEPI and PEP/LVET in patients with this diagnosis, makes it unlikely to have applied in our patients. Stack et al. (1976) has also described an even closer correlation between fractional shortening and PEP/LVET in patients with primary myocardial disease or coronary artery disease, which was not confirmed in the present study, the weak correlation demonstrated being of no clinical value in individual patients. It does seem, however, that the addition of ejection time in the ratio PEP/LVET increases the correlation with more widely measured variables such as Vcf or fractional shortening, compared with PEPI, at the expense of reducing its specificity as an index of incoordinate contraction.
The present results allow interpretations of previous observations on systolic time intervals to be extended. Pre-ejection period is prolonged in a proportion of patients with chronic ischaemic heart disease, particularly in those who develop left ventricular aneurysm (Jezek, 1963) or 'heart failure' (Weissler et al., 1969a) . Prolongation, to a lesser extent, may also occur in patients with angina pectoris even in the absence of other manifestations of left ventricular disease (Pouget et al., 1971) . These observations are all compatible with the incidence and associations of abnormal early systolic wall movement shown by angiography (Parker and Just, 1974) , since they fail to correlate with ejection fraction, 'contractility indices', or asynergy determined from inspection of ventriculograms. Demonstration of specific correlation with abnormal early systolic wall movement clarifies the genesis of prolongation of the preejection period and thus will help with the interpretation of abnormalities of the systolic time intervals observed in patients with left ventricular disease. It may also be possible to use the large amount of published information based on measurement of the systolic time intervals to extend appreciation of the physiological significance of the normal synchronous left ventricular wall movement and to assess the clinical and epidemiological consequences of incoordinate contraction. 
